Interpreting Outcomes of Intrathecal Therapy for Tuberculous Meningitis: Treatment Timing, Patient Selection, and Residual Uncertainty
Clinical Infectious Diseases · 07.10.2026
DOI: 10.1093/cid/ciag637 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 07.10.2026. Verfasst von Rui Chen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China. Die Arbeit nennt 3 Literaturangaben. Gefördert von: National Science and Technology Major Project, Shanghai Hospital Development Center.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.
- Department of Pulmonary and Critical Care Medicine, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
- Tuberculosis Research Center, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
ORCID-Profile: Rui Chen
Förderung
- National Science and Technology Major Project
- Shanghai Hospital Development Center
Zitieren
APA
Chen, R., & Li, F. (2026). Interpreting Outcomes of Intrathecal Therapy for Tuberculous Meningitis: Treatment Timing, Patient Selection, and Residual Uncertainty. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag637
Vancouver
Chen R, Li F. Interpreting Outcomes of Intrathecal Therapy for Tuberculous Meningitis: Treatment Timing, Patient Selection, and Residual Uncertainty. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciag637
BibTeX
@article{Chen2026,
author = {Chen, Rui and Li, Feng},
title = {Interpreting Outcomes of Intrathecal Therapy for Tuberculous Meningitis: Treatment Timing, Patient Selection, and Residual Uncertainty},
journal = {Clinical Infectious Diseases},
year = {2026},
doi = {10.1093/cid/ciag637}
}
EUVIMED